Press Releases 

Helomics® Corporation Names Dr. Mark Collins VP of Innovation and Strategy

PITTSBURGH–August 11, 2017 - Helomics® Corporation (Helomics), a privately-held, healthcare company providing personalized medicine solutions for clients in the pharmaceutical, diagnostic, and biotech industries, today announced the appointment of Mark Collins, Ph.D. as Vice President of Innovation and Strategy. Dr. Collins will be joining Helomics to drive the development of Helomics’ proprietary bioinformatics platform D-CHIP™ (Dynamic Clinical Health Insight Platform) and the utilization of the platform across all of Helomics’ business sectors. Dr. Collins has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and found

 Follow Us
  • LinkedIn Social Icon
  • Facebook Basic Square
  • Twitter Basic Square

© 2020 Helomics Corp. All rights reserved.

  • White Twitter Icon
  • Facebook - White Circle
  • White LinkedIn Icon